Zacks Investment Research
01 Oct 2026, 22:51 UTC · 1w ago
Amgen (AMGN) Stock Dips While Market Gains: Key Facts
Impact · against what's priced in
The article provides no new fundamental catalysts for Amgen; the reported price drop and consensus EPS/revenue estimates are consistent with existing market assumptions. The data confirms the baseline growth trajectory already reflected in the stock's valuation.
- AMGN+0.00
Already priced in
- The price assumes
The raised full-year revenue guidance of $38.2-$39.4 billion and non-GAAP EPS of $22.30-$23.50 are fully reflected.
The article's consensus projections of $22.94 EPS and $38.81 billion revenue fall squarely within the range already paid for in the reconstruction.
What AMGN's price assumes · Sep 12
Top 2 movers · tap to explore
